Nicholas Investment Partners, LP - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 279 filers reported holding CYTOKINETICS INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.

Quarter-by-quarter ownership
Nicholas Investment Partners, LP ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2023$27,755,356
+24.6%
942,137
+38.0%
2.07%
+36.1%
Q2 2023$22,275,122
+3.6%
682,867
+11.8%
1.52%
-6.8%
Q1 2023$21,500,738
-14.9%
610,990
+10.9%
1.63%
-26.2%
Q4 2022$25,252,685
+10.2%
551,128
+16.6%
2.21%
+4.2%
Q3 2022$22,909,000472,8392.12%
Other shareholders
CYTOKINETICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 223,382$6,580,8347.72%
Finepoint Capital LP 431,693$12,717,6766.33%
Saturn V Capital Management LP 495,168$14,587,6496.11%
Logos Global Management LP 1,250,000$36,825,0004.91%
DAFNA Capital Management LLC 479,538$14,127,1894.39%
PFM Health Sciences, LP 2,399,545$70,690,5963.33%
Boxer Capital, LLC 2,100,000$61,866,0003.29%
Integral Health Asset Management, LLC 800,000$23,568,0003.26%
GREAT POINT PARTNERS LLC 600,000$17,676,0003.22%
Nicholas Investment Partners, LP 942,137$27,755,3562.07%
View complete list of CYTOKINETICS INC shareholders